 | • レポートコード：GIR-2104Z04400 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、デジタル式コンパニオン診断のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。デジタル式コンパニオン診断の種類別市場規模（ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、In Situハイブリダイゼーション（ISH）、次世代シーケンシング（NGS））、用途別市場規模（病院、製薬会社、研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・デジタル式コンパニオン診断の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Roche Holdings (Switzerland)、Abbott Laboratories (US)、Thermo Fisher Scientific (US)、Agilent Technologies (US)、Life Technologies (US)、GE Healthcare (UK)、Agendia (Angola)、Qiagen (Germany)、Genomic Health (US)、Myriad Genetics (US)、Advanced Cell Diagnostics (US)、Danaher (US)、Applied Proteomics (US) ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ポリメラーゼ連鎖反応（PCR）、免疫組織化学（IHC）、In Situハイブリダイゼーション（ISH）、次世代シーケンシング（NGS） ・用途別分析2016年-2026年：病院、製薬会社、研究所、その他 ・デジタル式コンパニオン診断の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・デジタル式コンパニオン診断のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・デジタル式コンパニオン診断のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・デジタル式コンパニオン診断の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・デジタル式コンパニオン診断の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Digital Companion Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Digital Companion Diagnostics size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Digital Companion Diagnostics market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Digital Companion Diagnostics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polymerase Chain Reaction (PCR)
Immunohistochemistry (IHC)
In Situ Hybridization (ISH)
Next Generation Sequencing (NGS)
Market segment by Application, can be divided into
Hospitals
Pharmaceutical Companies
Laboratories
Other
Market segment by players, this report covers
Roche Holdings (Switzerland)
Abbott Laboratories (US)
Thermo Fisher Scientific (US)
Agilent Technologies (US)
Life Technologies (US)
GE Healthcare (UK)
Agendia (Angola)
Qiagen (Germany)
Genomic Health (US)
Myriad Genetics (US)
Advanced Cell Diagnostics (US)
Danaher (US)
Applied Proteomics (US)
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Digital Companion Diagnostics
1.2 Classification of Digital Companion Diagnostics by Type
1.2.1 Overview: Global Digital Companion Diagnostics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Digital Companion Diagnostics Revenue Market Share by Type in 2020
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Immunohistochemistry (IHC)
1.2.5 In Situ Hybridization (ISH)
1.2.6 Next Generation Sequencing (NGS)
1.3 Global Digital Companion Diagnostics Market by Application
1.3.1 Overview: Global Digital Companion Diagnostics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Pharmaceutical Companies
1.3.4 Laboratories
1.3.5 Other
1.4 Global Digital Companion Diagnostics Market Size & Forecast
1.5 Global Digital Companion Diagnostics Market Size and Forecast by Region
1.5.1 Global Digital Companion Diagnostics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Digital Companion Diagnostics Market Size by Region, (2016-2021)
1.5.3 North America Digital Companion Diagnostics Market Size and Prospect (2016-2026)
1.5.4 Europe Digital Companion Diagnostics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Digital Companion Diagnostics Market Size and Prospect (2016-2026)
1.5.6 South America Digital Companion Diagnostics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Digital Companion Diagnostics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Digital Companion Diagnostics Market Drivers
1.6.2 Digital Companion Diagnostics Market Restraints
1.6.3 Digital Companion Diagnostics Trends Analysis
2 Company Profiles
2.1 Roche Holdings (Switzerland)
2.1.1 Roche Holdings (Switzerland) Details
2.1.2 Roche Holdings (Switzerland) Major Business
2.1.3 Roche Holdings (Switzerland) Digital Companion Diagnostics Product and Solutions
2.1.4 Roche Holdings (Switzerland) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Roche Holdings (Switzerland) Recent Developments and Future Plans
2.2 Abbott Laboratories (US)
2.2.1 Abbott Laboratories (US) Details
2.2.2 Abbott Laboratories (US) Major Business
2.2.3 Abbott Laboratories (US) Digital Companion Diagnostics Product and Solutions
2.2.4 Abbott Laboratories (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Abbott Laboratories (US) Recent Developments and Future Plans
2.3 Thermo Fisher Scientific (US)
2.3.1 Thermo Fisher Scientific (US) Details
2.3.2 Thermo Fisher Scientific (US) Major Business
2.3.3 Thermo Fisher Scientific (US) Digital Companion Diagnostics Product and Solutions
2.3.4 Thermo Fisher Scientific (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Thermo Fisher Scientific (US) Recent Developments and Future Plans
2.4 Agilent Technologies (US)
2.4.1 Agilent Technologies (US) Details
2.4.2 Agilent Technologies (US) Major Business
2.4.3 Agilent Technologies (US) Digital Companion Diagnostics Product and Solutions
2.4.4 Agilent Technologies (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Agilent Technologies (US) Recent Developments and Future Plans
2.5 Life Technologies (US)
2.5.1 Life Technologies (US) Details
2.5.2 Life Technologies (US) Major Business
2.5.3 Life Technologies (US) Digital Companion Diagnostics Product and Solutions
2.5.4 Life Technologies (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Life Technologies (US) Recent Developments and Future Plans
2.6 GE Healthcare (UK)
2.6.1 GE Healthcare (UK) Details
2.6.2 GE Healthcare (UK) Major Business
2.6.3 GE Healthcare (UK) Digital Companion Diagnostics Product and Solutions
2.6.4 GE Healthcare (UK) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 GE Healthcare (UK) Recent Developments and Future Plans
2.7 Agendia (Angola)
2.7.1 Agendia (Angola) Details
2.7.2 Agendia (Angola) Major Business
2.7.3 Agendia (Angola) Digital Companion Diagnostics Product and Solutions
2.7.4 Agendia (Angola) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Agendia (Angola) Recent Developments and Future Plans
2.8 Qiagen (Germany)
2.8.1 Qiagen (Germany) Details
2.8.2 Qiagen (Germany) Major Business
2.8.3 Qiagen (Germany) Digital Companion Diagnostics Product and Solutions
2.8.4 Qiagen (Germany) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Qiagen (Germany) Recent Developments and Future Plans
2.9 Genomic Health (US)
2.9.1 Genomic Health (US) Details
2.9.2 Genomic Health (US) Major Business
2.9.3 Genomic Health (US) Digital Companion Diagnostics Product and Solutions
2.9.4 Genomic Health (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Genomic Health (US) Recent Developments and Future Plans
2.10 Myriad Genetics (US)
2.10.1 Myriad Genetics (US) Details
2.10.2 Myriad Genetics (US) Major Business
2.10.3 Myriad Genetics (US) Digital Companion Diagnostics Product and Solutions
2.10.4 Myriad Genetics (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Myriad Genetics (US) Recent Developments and Future Plans
2.11 Advanced Cell Diagnostics (US)
2.11.1 Advanced Cell Diagnostics (US) Details
2.11.2 Advanced Cell Diagnostics (US) Major Business
2.11.3 Advanced Cell Diagnostics (US) Digital Companion Diagnostics Product and Solutions
2.11.4 Advanced Cell Diagnostics (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Advanced Cell Diagnostics (US) Recent Developments and Future Plans
2.12 Danaher (US)
2.12.1 Danaher (US) Details
2.12.2 Danaher (US) Major Business
2.12.3 Danaher (US) Digital Companion Diagnostics Product and Solutions
2.12.4 Danaher (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.12.5 Danaher (US) Recent Developments and Future Plans
2.13 Applied Proteomics (US)
2.13.1 Applied Proteomics (US) Details
2.13.2 Applied Proteomics (US) Major Business
2.13.3 Applied Proteomics (US) Digital Companion Diagnostics Product and Solutions
2.13.4 Applied Proteomics (US) Digital Companion Diagnostics Revenue, Gross Margin and Market Share (2019-2021)
2.13.5 Applied Proteomics (US) Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Digital Companion Diagnostics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Digital Companion Diagnostics Players Market Share
3.2.2 Top 10 Digital Companion Diagnostics Players Market Share
3.2.3 Market Competition Trend
3.3 Digital Companion Diagnostics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Digital Companion Diagnostics Revenue and Market Share by Type (2016-2021)
4.2 Global Digital Companion Diagnostics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Digital Companion Diagnostics Revenue Market Share by Application (2016-2021)
5.2 Digital Companion Diagnostics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Digital Companion Diagnostics Revenue by Type (2016-2026)
6.2 North America Digital Companion Diagnostics Revenue by Application (2016-2026)
6.3 North America Digital Companion Diagnostics Market Size by Country
6.3.1 North America Digital Companion Diagnostics Revenue by Country (2016-2026)
6.3.2 United States Digital Companion Diagnostics Market Size and Forecast (2016-2026)
6.3.3 Canada Digital Companion Diagnostics Market Size and Forecast (2016-2026)
6.3.4 Mexico Digital Companion Diagnostics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Digital Companion Diagnostics Revenue by Type (2016-2026)
7.2 Europe Digital Companion Diagnostics Revenue by Application (2016-2026)
7.3 Europe Digital Companion Diagnostics Market Size by Country
7.3.1 Europe Digital Companion Diagnostics Revenue by Country (2016-2026)
7.3.2 Germany Digital Companion Diagnostics Market Size and Forecast (2016-2026)
7.3.3 France Digital Companion Diagnostics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Digital Companion Diagnostics Market Size and Forecast (2016-2026)
7.3.5 Russia Digital Companion Diagnostics Market Size and Forecast (2016-2026)
7.3.6 Italy Digital Companion Diagnostics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Digital Companion Diagnostics Revenue by Type (2016-2026)
8.2 Asia-Pacific Digital Companion Diagnostics Revenue by Application (2016-2026)
8.3 Asia-Pacific Digital Companion Diagnostics Market Size by Region
8.3.1 Asia-Pacific Digital Companion Diagnostics Revenue by Region (2016-2026)
8.3.2 China Digital Companion Diagnostics Market Size and Forecast (2016-2026)
8.3.3 Japan Digital Companion Diagnostics Market Size and Forecast (2016-2026)
8.3.4 South Korea Digital Companion Diagnostics Market Size and Forecast (2016-2026)
8.3.5 India Digital Companion Diagnostics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Digital Companion Diagnostics Market Size and Forecast (2016-2026)
8.3.7 Australia Digital Companion Diagnostics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Digital Companion Diagnostics Revenue by Type (2016-2026)
9.2 South America Digital Companion Diagnostics Revenue by Application (2016-2026)
9.3 South America Digital Companion Diagnostics Market Size by Country
9.3.1 South America Digital Companion Diagnostics Revenue by Country (2016-2026)
9.3.2 Brazil Digital Companion Diagnostics Market Size and Forecast (2016-2026)
9.3.3 Argentina Digital Companion Diagnostics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Digital Companion Diagnostics Revenue by Type (2016-2026)
10.2 Middle East & Africa Digital Companion Diagnostics Revenue by Application (2016-2026)
10.3 Middle East & Africa Digital Companion Diagnostics Market Size by Country
10.3.1 Middle East & Africa Digital Companion Diagnostics Revenue by Country (2016-2026)
10.3.2 Turkey Digital Companion Diagnostics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Digital Companion Diagnostics Market Size and Forecast (2016-2026)
10.3.4 UAE Digital Companion Diagnostics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Digital Companion Diagnostics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Digital Companion Diagnostics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Digital Companion Diagnostics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Digital Companion Diagnostics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Digital Companion Diagnostics Revenue Market Share by Region (2021-2026)
Table 6. Roche Holdings (Switzerland) Corporate Information, Head Office, and Major Competitors
Table 7. Roche Holdings (Switzerland) Major Business
Table 8. Roche Holdings (Switzerland) Digital Companion Diagnostics Product and Solutions
Table 9. Roche Holdings (Switzerland) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Abbott Laboratories (US) Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories (US) Major Business
Table 12. Abbott Laboratories (US) Digital Companion Diagnostics Product and Solutions
Table 13. Abbott Laboratories (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Thermo Fisher Scientific (US) Corporate Information, Head Office, and Major Competitors
Table 15. Thermo Fisher Scientific (US) Major Business
Table 16. Thermo Fisher Scientific (US) Digital Companion Diagnostics Product and Solutions
Table 17. Thermo Fisher Scientific (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Agilent Technologies (US) Corporate Information, Head Office, and Major Competitors
Table 19. Agilent Technologies (US) Major Business
Table 20. Agilent Technologies (US) Digital Companion Diagnostics Product and Solutions
Table 21. Agilent Technologies (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Life Technologies (US) Corporate Information, Head Office, and Major Competitors
Table 23. Life Technologies (US) Major Business
Table 24. Life Technologies (US) Digital Companion Diagnostics Product and Solutions
Table 25. Life Technologies (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. GE Healthcare (UK) Corporate Information, Head Office, and Major Competitors
Table 27. GE Healthcare (UK) Major Business
Table 28. GE Healthcare (UK) Digital Companion Diagnostics Product and Solutions
Table 29. GE Healthcare (UK) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Agendia (Angola) Corporate Information, Head Office, and Major Competitors
Table 31. Agendia (Angola) Major Business
Table 32. Agendia (Angola) Digital Companion Diagnostics Product and Solutions
Table 33. Agendia (Angola) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Qiagen (Germany) Corporate Information, Head Office, and Major Competitors
Table 35. Qiagen (Germany) Major Business
Table 36. Qiagen (Germany) Digital Companion Diagnostics Product and Solutions
Table 37. Qiagen (Germany) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Genomic Health (US) Corporate Information, Head Office, and Major Competitors
Table 39. Genomic Health (US) Major Business
Table 40. Genomic Health (US) Digital Companion Diagnostics Product and Solutions
Table 41. Genomic Health (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Myriad Genetics (US) Corporate Information, Head Office, and Major Competitors
Table 43. Myriad Genetics (US) Major Business
Table 44. Myriad Genetics (US) Digital Companion Diagnostics Product and Solutions
Table 45. Myriad Genetics (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Advanced Cell Diagnostics (US) Corporate Information, Head Office, and Major Competitors
Table 47. Advanced Cell Diagnostics (US) Major Business
Table 48. Advanced Cell Diagnostics (US) Digital Companion Diagnostics Product and Solutions
Table 49. Advanced Cell Diagnostics (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Danaher (US) Corporate Information, Head Office, and Major Competitors
Table 51. Danaher (US) Major Business
Table 52. Danaher (US) Digital Companion Diagnostics Product and Solutions
Table 53. Danaher (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 54. Applied Proteomics (US) Corporate Information, Head Office, and Major Competitors
Table 55. Applied Proteomics (US) Major Business
Table 56. Applied Proteomics (US) Digital Companion Diagnostics Product and Solutions
Table 57. Applied Proteomics (US) Digital Companion Diagnostics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 58. Global Digital Companion Diagnostics Revenue (USD Million) by Players (2019-2021)
Table 59. Global Digital Companion Diagnostics Revenue Share by Players (2019-2021)
Table 60. Breakdown of Digital Companion Diagnostics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Digital Companion Diagnostics Players Head Office, Products and Services Provided
Table 62. Digital Companion Diagnostics Mergers & Acquisitions in the Past Five Years
Table 63. Digital Companion Diagnostics New Entrants and Expansion Plans
Table 64. Global Digital Companion Diagnostics Revenue (USD Million) by Type (2016-2021)
Table 65. Global Digital Companion Diagnostics Revenue Share by Type (2016-2021)
Table 66. Global Digital Companion Diagnostics Revenue Forecast by Type (2021-2026)
Table 67. Global Digital Companion Diagnostics Revenue by Application (2016-2021)
Table 68. Global Digital Companion Diagnostics Revenue Forecast by Application (2021-2026)
Table 69. North America Digital Companion Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 70. North America Digital Companion Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 71. North America Digital Companion Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 72. North America Digital Companion Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 73. North America Digital Companion Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 74. North America Digital Companion Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 75. Europe Digital Companion Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 76. Europe Digital Companion Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 77. Europe Digital Companion Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 78. Europe Digital Companion Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 79. Europe Digital Companion Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 80. Europe Digital Companion Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 81. Asia-Pacific Digital Companion Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 82. Asia-Pacific Digital Companion Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 83. Asia-Pacific Digital Companion Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 84. Asia-Pacific Digital Companion Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 85. Asia-Pacific Digital Companion Diagnostics Revenue by Region (2016-2021) & (USD Million)
Table 86. Asia-Pacific Digital Companion Diagnostics Revenue by Region (2021-2026) & (USD Million)
Table 87. South America Digital Companion Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 88. South America Digital Companion Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 89. South America Digital Companion Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 90. South America Digital Companion Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 91. South America Digital Companion Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 92. South America Digital Companion Diagnostics Revenue by Country (2021-2026) & (USD Million)
Table 93. Middle East & Africa Digital Companion Diagnostics Revenue by Type (2016-2021) & (USD Million)
Table 94. Middle East & Africa Digital Companion Diagnostics Revenue by Type (2021-2026) & (USD Million)
Table 95. Middle East & Africa Digital Companion Diagnostics Revenue by Application (2016-2021) & (USD Million)
Table 96. Middle East & Africa Digital Companion Diagnostics Revenue by Application (2021-2026) & (USD Million)
Table 97. Middle East & Africa Digital Companion Diagnostics Revenue by Country (2016-2021) & (USD Million)
Table 98. Middle East & Africa Digital Companion Diagnostics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Digital Companion Diagnostics Picture
Figure 2. Global Digital Companion Diagnostics Revenue Market Share by Type in 2020
Figure 3. Polymerase Chain Reaction (PCR)
Figure 4. Immunohistochemistry (IHC)
Figure 5. In Situ Hybridization (ISH)
Figure 6. Next Generation Sequencing (NGS)
Figure 7. Digital Companion Diagnostics Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Pharmaceutical Companies Picture
Figure 10. Laboratories Picture
Figure 11. Other Picture
Figure 12. Global Digital Companion Diagnostics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Digital Companion Diagnostics Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Digital Companion Diagnostics Revenue Market Share by Region (2016-2026)
Figure 15. Global Digital Companion Diagnostics Revenue Market Share by Region in 2020
Figure 16. North America Digital Companion Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Digital Companion Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Digital Companion Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Digital Companion Diagnostics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Digital Companion Diagnostics Market Drivers
Figure 21. Digital Companion Diagnostics Market Restraints
Figure 22. Digital Companion Diagnostics Market Trends
Figure 23. Roche Holdings (Switzerland) Recent Developments and Future Plans
Figure 24. Abbott Laboratories (US) Recent Developments and Future Plans
Figure 25. Thermo Fisher Scientific (US) Recent Developments and Future Plans
Figure 26. Agilent Technologies (US) Recent Developments and Future Plans
Figure 27. Life Technologies (US) Recent Developments and Future Plans
Figure 28. GE Healthcare (UK) Recent Developments and Future Plans
Figure 29. Agendia (Angola) Recent Developments and Future Plans
Figure 30. Qiagen (Germany) Recent Developments and Future Plans
Figure 31. Genomic Health (US) Recent Developments and Future Plans
Figure 32. Myriad Genetics (US) Recent Developments and Future Plans
Figure 33. Advanced Cell Diagnostics (US) Recent Developments and Future Plans
Figure 34. Danaher (US) Recent Developments and Future Plans
Figure 35. Applied Proteomics (US) Recent Developments and Future Plans
Figure 37. Global Digital Companion Diagnostics Revenue Share by Players in 2020
Figure 38. Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 39. Global Top 3 Players Digital Companion Diagnostics Revenue Market Share in 2020
Figure 40. Global Top 10 Players Digital Companion Diagnostics Revenue Market Share in 2020
Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 42. Global Digital Companion Diagnostics Revenue Share by Type in 2020
Figure 43. Global Digital Companion Diagnostics Market Share Forecast by Type (2021-2026)
Figure 44. Global Digital Companion Diagnostics Revenue Share by Application in 2020
Figure 45. Global Digital Companion Diagnostics Market Share Forecast by Application (2021-2026)
Figure 46. North America Digital Companion Diagnostics Sales Market Share by Type (2016-2026)
Figure 47. North America Digital Companion Diagnostics Sales Market Share by Application (2016-2026)
Figure 48. North America Digital Companion Diagnostics Revenue Market Share by Country (2016-2026)
Figure 49. United States Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Canada Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Mexico Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Europe Digital Companion Diagnostics Sales Market Share by Type (2016-2026)
Figure 53. Europe Digital Companion Diagnostics Sales Market Share by Application (2016-2026)
Figure 54. Europe Digital Companion Diagnostics Revenue Market Share by Country (2016-2026)
Figure 55. Germany Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. France Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. United Kingdom Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Russia Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Italy Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Asia-Pacific Digital Companion Diagnostics Sales Market Share by Type (2016-2026)
Figure 61. Asia-Pacific Digital Companion Diagnostics Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Digital Companion Diagnostics Revenue Market Share by Region (2016-2026)
Figure 63. China Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Japan Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South Korea Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. India Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Southeast Asia Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Australia Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. South America Digital Companion Diagnostics Sales Market Share by Type (2016-2026)
Figure 70. South America Digital Companion Diagnostics Sales Market Share by Application (2016-2026)
Figure 71. South America Digital Companion Diagnostics Revenue Market Share by Country (2016-2026)
Figure 72. Brazil Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Argentina Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Middle East and Africa Digital Companion Diagnostics Sales Market Share by Type (2016-2026)
Figure 75. Middle East and Africa Digital Companion Diagnostics Sales Market Share by Application (2016-2026)
Figure 76. Middle East and Africa Digital Companion Diagnostics Revenue Market Share by Country (2016-2026)
Figure 77. Turkey Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. Saudi Arabia Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. UAE Digital Companion Diagnostics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 80. Methodology
Figure 81. Research Process and Data Source
世界のデジタルコンパニオン診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Digital Companion Diagnostics Market The global Digital Companion Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…- 世界のデジタルコンパニオン診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Digital Companion Diagnostics Market The global Digital Companion Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界のコンパニオン診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Companion Diagnostics Market The global Companion Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report…
- 世界のコンパニオン診断市場 2021：企業別、地域別、種類・用途別 The Companion Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の薬理ゲノミクス技術/セラノスティクス/コンパニオン診断（CDx）市場 2021：企業別、地域別、種類・用途別 The Pharmacogenomics Technology/Theranostics/Companion Diagnostics (CDx) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market pla…